Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa, Single-Site, Open-Label Trial of Baricitinib in Patients With Cardiac Sarcoidosis

NCT06868381 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06868381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa, Single-Site, Open-Label Trial of Baricitinib in Patients With Cardiac Sarcoidosis
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
December 1, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac sarcoidosis